GN Store Nord (GN) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
5 Feb, 2026Executive summary
Achieved -1% organic growth in 2025, with strong performance in Hearing (+5%), offset by declines in Enterprise (-6%) and Gaming (-2%), while gaining market share and executing well despite challenging conditions.
EBITA margin reached 11.4% for the year, reflecting effective cost control, pricing initiatives, and an extraordinary R&D write-down.
Free cash flow (excl. M&A) was DKK 1.1 billion, supporting balance sheet improvement, deleveraging, and debt reduction.
Product innovation and launches, notably the Evolve3 headset and Vivya platform, are expected to drive future growth.
Strengthened business fundamentals and prepared for profitable growth in 2026 through innovation and cost control.
Financial highlights
Q4 2025 organic revenue growth was -2%; full-year organic revenue growth was -1%.
Q4 EBITA margin was 13.4%, impacted by an extraordinary R&D write-down related to a new partnership.
Net interest-bearing debt reduced by over DKK 800 million, enabling refinancing at attractive terms.
Free cash flow for Q4 (excl. M&A) was DKK 744 million; full-year DKK 1,112 million.
Net profit for 2025 was DKK 710 million, with EPS at 4.48.
Outlook and guidance
2026 group organic revenue growth guided at 3%-7%, with EBITA margin of 11.5%-13.5%.
Underlying margin expansion of 1-3 percentage points expected, driven by revenue growth and operational leverage.
Hearing expected to grow 3%-7%, Enterprise 0%-6%, and Gaming 7%-13% in 2026.
Long-term EBITA margin target remains 16%-17%, with margin expansion expected beyond 2026.
Growth in 2026 expected to be back-end loaded, especially in Enterprise and Gaming.
Latest events from GN Store Nord
- Hearing business sold to Amplifon for DKK 17B, enabling tech focus and global audiology leadership.GN
M&A announcement16 Mar 2026 - Pursuing margin expansion and growth through innovation in hearing, enterprise, and gaming.GN
SEB Nordic Seminar presentation5 Feb 2026 - 5% organic growth and margin gains, with strong Hearing and Gaming, guidance confirmed.GN
Q2 202423 Jan 2026 - Record cash flow and margin gains as Hearing outperformed, offsetting mixed divisional growth.GN
Q3 202416 Jan 2026 - Strong EBITDA growth, new board members, and strategic focus on innovation and resilience.GN
AGM 202520 Dec 2025 - Strong 2024 growth and margin gains set the stage for further expansion in 2025.GN
Q4 202417 Dec 2025 - Organic revenue fell 3%, but margin gains and new launches support cautious optimism.GN
Q1 202529 Nov 2025 - EBITA up 46% on margin gains, with Hearing strong and 2025 guidance narrowed amid tariff risks.GN
Q2 202523 Nov 2025 - Q3 2025 saw 1% organic growth, 11% EBITA margin, and strong cash flow, led by Hearing.GN
Q3 202513 Nov 2025